A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma - PubMed (original) (raw)
. 1991 Dec 13;254(5038):1643-7.
doi: 10.1126/science.1840703.
Affiliations
- PMID: 1840703
- DOI: 10.1126/science.1840703
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
P van der Bruggen et al. Science. 1991.
Abstract
Many human melanoma tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. A gene was identified that directed the expression of antigen MZ2-E on a human melanoma cell line. This gene shows no similarity to known sequences and belongs to a family of at least three genes. It is expressed by the original melanoma cells, other melanoma cell lines, and by some tumor cells of other histological types. No expression was observed in a panel of normal tissues. Antigen MZ2-E appears to be presented by HLA-A1; anti-MZ2-E CTLs of the original patient recognized two melanoma cell lines of other HLA-A1 patients that expressed the gene. Thus, precisely targeted immunotherapy directed against antigen MZ2-E could be provided to individuals identified by HLA typing and analysis of the RNA of a small tumor sample.
Republished in
- A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde BJ, Knuth A, Boon T. van der Bruggen P, et al. J Immunol. 2007 Mar 1;178(5):2617-21. J Immunol. 2007. PMID: 17312099 No abstract available.
Similar articles
- Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.
Marchand M, Brasseur F, van der Bruggen P, Coulie P, Boon T. Marchand M, et al. Dermatology. 1993;186(4):278-80. doi: 10.1159/000247375. Dermatology. 1993. PMID: 8513199 - A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. Van den Eynde B, et al. J Exp Med. 1995 Sep 1;182(3):689-98. doi: 10.1084/jem.182.3.689. J Exp Med. 1995. PMID: 7544395 Free PMC article. - Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T. Gaugler B, et al. J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921. J Exp Med. 1994. PMID: 8113684 Free PMC article. - Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T. Coulie PG, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):104-9. doi: 10.1097/00002371-199308000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280701 Review. - Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.
Boon T. Boon T. Int J Cancer. 1993 May 8;54(2):177-80. doi: 10.1002/ijc.2910540202. Int J Cancer. 1993. PMID: 8486420 Review. No abstract available.
Cited by
- Development and characterization of human T-cell receptor (TCR) alpha and beta clones' library as biological standards and resources for TCR sequencing and engineering.
Wei YC, Pospiech M, Meng Y, Alachkar H. Wei YC, et al. Biol Methods Protoc. 2024 Sep 5;9(1):bpae064. doi: 10.1093/biomethods/bpae064. eCollection 2024. Biol Methods Protoc. 2024. PMID: 39507623 Free PMC article. - Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma.
Zhuo S, Yang S, Chen S, Ding Y, Cheng H, Yang L, Wang K, Yang K. Zhuo S, et al. Discov Oncol. 2024 Oct 29;15(1):602. doi: 10.1007/s12672-024-01449-4. Discov Oncol. 2024. PMID: 39472405 Free PMC article. Review. - Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.
Chi WY, Hu Y, Huang HC, Kuo HH, Lin SH, Kuo CJ, Tao J, Fan D, Huang YM, Wu AA, Hung CF, Wu TC. Chi WY, et al. J Biomed Sci. 2024 Oct 9;31(1):94. doi: 10.1186/s12929-024-01082-x. J Biomed Sci. 2024. PMID: 39379923 Free PMC article. Review. - Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.
Amin T, Hossain A, Jerin N, Mahmud I, Rahman MA, Rafiqul Islam SM, Islam SMBU. Amin T, et al. Cancer Control. 2024 Jan-Dec;31:10732748241290067. doi: 10.1177/10732748241290067. Cancer Control. 2024. PMID: 39353594 Free PMC article. Review. - Developing an erythrocyte‒MHC-I conjugate for cancer treatment.
Liu Y, Nie X, Yao X, Shou H, Yuan Y, Ge Y, Tong X, Lee HY, Gao X. Liu Y, et al. Cell Discov. 2024 Oct 1;10(1):99. doi: 10.1038/s41421-024-00713-9. Cell Discov. 2024. PMID: 39349449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials